Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
The discovery that pain receptors continue to function within nerves may lead to more effective pain medications with fewer side effects.
Columbia’s neurology department launches new research division to study outcomes as more treatments become available to help neurological patients.
Interdisciplinary dermatology research is helping advance understanding of conditions like alopecia areata, epidermolysis bullosa, and skin cancer.
Among the P&S faculty and students are many exceptional military veterans whose experience drives their careers.
Helen H. Lu and her research team specialize in growing multiple tissues to build functional organ systems that assimilate with the body.
Setting goals or making resolutions is a great idea—as long as you do so in a way that makes success more likely.
Find out what’s been going on across campus. All four schools recently published new CUMC magazines.
The two schools will jointly study physical activity and how the built environment can support physically active lifestyles.
With a seemingly endless stream of holiday songs, window displays, and sidewalk Santas, it is virtually impossible to resist the call to holiday cheer. Or is it?
Columbia has played an important role in studying RAISE treatment model for early schizophrenia, which heads NIMH director’s top 10 list of notable achievements in 2014.
People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors. Now a large-scale analysis of hundreds of patients and nearly 1000 genes has started to uncover how diversity among traits can be traced to differences in patients’ genetic mutations.